Realm Therapeutics - Block listing Interim Review

February 16, 2018
RNS Number : 3663E
Realm Therapeutics PLC
16 February 2018
 

Realm Therapeutics plc

Block Listing Interim Review

 

Pursuant to AIM Rule 29 and Schedule 6 of the AIM Rules for Companies Realm Therapeutics plc makes the following update on its block listing:

 

Date: 16 February 2018

 

Name of applicant:

Realm Therapeutics plc

Name of scheme:

Executive Omnibus Incentive Plan

Warrants

Figures for all schemes relate to ordinary shares of 10 pence each

Period of return:

From: 18 August 2017 To: 15 February 2018

Balance of unallotted securities under scheme(s) from previous return:

2,055,362

117,195

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

Nil

21,139,826

Less:  Number of securities issued/allotted under scheme(s) during period:

Nil

Nil

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

2,055,362

21,257,021

 

Number and class of securities originally admitted:* these securities have been adjusted for a 1 for 10 share consolidation which took effect on 2 July 2010

*20,000 and *378,423 + *32,000 and 200,000

*196,087 and *21,108

Dates of Admission:

7 August 2006 and 31 August 2007 and 15 August 2012

7 August 2006 and 31 August 2007

Name of contact:

Marella Thorell, Company Secretary

Telephone number of contact:

+1 484-321-2749

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BLRBUGDDCUGBGII

Search Investor Relations